LONA
LeonaBio, Inc.
$8.87
+0.49 (+5.85%)
At close · Jul 2
Market Cap
$83.32M
Shares
9,393,514
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$8.87
Open$8.82
Day$8.37–9.04
52W$2.90–14.21
Avg vol 30d27K
Short int52K · 0.5% float · 2.9d
Short vol39%
Last earningsMay 7, 2026
DataSep 2020–Jul 2026
Filing10-Q · May 7
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+34% above
◦
Price vs 50-day avg
−3% below
◦
RSI (14)
50 · neutral
+
MACD trend
positive
◦
52-week position
53% · mid-range
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $9 › 200d $7 — 50d above 200d
−
Institutional flow
-5% holders QoQ · +6 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.55% of float · ▼ -8.8% MoM · 2.9 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
40 holders — 13F breadth
Fundamentals
Fair
◦
EPS growth
+2% Y/Y
−
Free cash flow
$-45.8M
+
Balance sheet
net cash $69.3M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 6, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+34% above
Bullish
Price vs 50-day avg
−3% below
Neutral
RSI (14)
50 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
53% · mid-range
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $9 › 200d $7 — 50d above 200d
Institutional flow
Distributing
-5% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.55% of float · ▼ -8.8% MoM · 2.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
40 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $3
Now $9 · 53%
52-wk high $14
vs 200-day avg +34%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LONA
this stock
LeonaBio, Inc.
|
$83.32M | +17.2% | — | — | 0.5% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LONA | +2.1% | +2.8% | +23.4% | -3.5% | +17.2% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +0.6% | +4.0% | +15.4% | -3.2% | +8.0% |